TABLE 7.

Results of pairwise meta-analyses for extracranial hemorrhage.

Comparative medication	Reference medication	Number of studies	Pairwise meta-analyses
			Number of control	Number of patients	MD/OR/RR	95% CI	I2	P
Heparin	Placebo	9	288	330	0.71	[0.25, 2.05]	32	0.22
Safflower yellow	Placebo	7	368	394	NA	NA	0	0.93
Stent retrievers	Placebo	5	652	634	1.08	[0.64, 2.30]	0	0.63
Ginkgo biloba	Placebo	12	266	281	0.82	[0.43, 1.57]	0	0.443
Tirofiban	Placebo	6	216	213	1.14	[0.72, 1.82]	0	0.57
Edaravone plus rt-PA	Placebo	8	221	221	0.44	[0.29, 0.66]	0	0.93
Alpha 1	Placebo	6	467	595	1.25	[0.97, 1.62]	9	0.09
TNK	Placebo	4	658	676	1.07	[0.6, 1.93]	0	0.81
MTE plus stent retrievers	Placebo	5	146	144	0.59	[0.35,0.97]	0	0.83
MTE	Placebo	5	141	140	3.05	[0.44, 21.23]	0	0.25
tPA plus MTE	Placebo	7	2639	2640	0.93	[0.72, 1.19]	29	0.13
Cilostazol	Placebo	6	1728	1731	0.29	[0.15, 0.56]	0	0.77

CI, confidence interval; MD, mean difference; OR, risk ratio; I², heterogeneity, TNK, tenecteplase.